Ferris Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Ferris Capital's ABBV Position: Q1 2022 in Review
Ferris Capital reduced its AbbVie (ABBV) stake by 18% in Q1 2022, selling an estimated $141K and leaving 4,493 shares worth $728K. The position accounts for 0.17% of the portfolio, ranked #112.
Ferris Capital first reported a position in ABBV in Q2 2017 and has held it in 14 quarters since. The position peaked at $740K in Q4 2021. 3,053 funds tracked by Wall St. Rank hold ABBV as of Q1 2022.
- Ferris Capital held 4,493 shares of AbbVie worth $728K as of Q1 2022.
- Ferris Capital sold 971 AbbVie shares in Q1 2022, an estimated $141K.
- AbbVie made up 0.17% of Ferris Capital's portfolio in Q1 2022, its #112 holding.
- Ferris Capital first reported a position in AbbVie in Q2 2017 and has held it in 14 quarters since.
- Ferris Capital's AbbVie position peaked at $740K in Q4 2021.
- 3,053 funds tracked by Wall St. Rank held AbbVie as of Q1 2022.
Based on Ferris Capital's 13F filing for Q1 2022, filed 13 May 2022.